Author

C. E. Tognon

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Cheltsov· 1 shared A. Nilsen· 1 shared B. Druker· 1 shared C. Boniface· 1 shared D. Bottomly· 1 shared D. Rozanov· 1 shared E. Traer· 1 shared G. B. Mills· 1 shared

Activity by Year

2018-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Cheltsov

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivJan 27, 2021

A noncanonical FLT3 gatekeeper mutation disrupts gilteritinib binding and confers resistance

S. K. Joshi, S. Sharzehi, J. Pittsenbarger…·E. Traer

This study identifies a novel FLT3 mutation, N701K, that confers resistance to gilteritinib by blocking its binding, and suggests switching to type 2 FLT3 inhibitors may be effective.

DOI 10.1002/ajh.26174

humanexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivOct 1, 2018

Targeting mitochondria in cancer therapy could provide a basis for the selective anti-cancer activity

D. Rozanov, A. Cheltsov, A. Nilsen…·P. Spellman

The paper identifies key factors distinguishing non-toxic and toxic compounds targeting mitochondria in cancer therapy using SAR studies and a mathematical model.

DOI 10.1371/journal.pone.0205623

humanstatistical model

𝕏 PostBluesky